In the present study we used the AppNL-G-F model that express human Aβ with knock-in of NL-G-F mutations into the endogenous mouse App gene (13), circumventing APP overexpression artefacts of earlier transgenic AD models. This evidence concerns the gene APP and Alzheimer disease.